In contrast to abundant studies showing that MIF is a key factor in tumor immune response, recently it has been found that its cognate receptor CD74 is confined to human microglia/macrophages and is positively associated with pro-inflammatory anti-tumor immune responses and improved patients’ survival [105]. Here, MIF is linked to neoplasm.